Study finds IgE antibody levels double with increasing age

NewsGuard 100/100 Score

In the first such study since the 1970s, researchers observed a highly statistically significant increase of IgE, a type of antibody associated with allergic reactions. The new study, presented at the American College of Allergy, Asthma and Immunology annual meeting in Phoenix Nov 11-16, examined IgE levels in subjects from the National Health and Nutrition Survey (NHANES), a large cross-sectional U.S. population survey conducted by the National Center for Health Statistics, in 2005-2006.

They then compared the results of their research to the Tucson Epidemiological Study (TES), which examined similar data from the 1970s. "Particularly noteworthy is the doubling of IgE levels in individuals over 55 years, and the more gradual decline in levels with increasing age," wrote the authors. They attribute possible reasons for the increase to "allergic sensitization in our population or changes in lab testing."

Title: Quantitative Increase in Age-Related IgE In United States Population
Coauthors: ACAAI Members Zachary David Jacobs, MD, and Chitra Dinaker, MD, Children's Mercy Hospital & Clinic, Kansas City, MO

By the numbers:
A nationwide survey found more than half of all U.S. citizens test positive to one or more allergens. Often, people don't realize it's allergy that is causing their symptoms. Allergists have the training and expertise to treat more than just symptoms. They can identify the source of your suffering and develop a treatment plan to eliminate the symptoms.

Source: ACAAI

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study finds maternal vaccine and monoclonal antibody effective against RSV in infants